These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28209627)

  • 1. Characterization of a Blood Spot Creatine Kinase Skeletal Muscle Isoform Immunoassay for High-Throughput Newborn Screening of Duchenne Muscular Dystrophy.
    Moat SJ; Korpimäki T; Furu P; Hakala H; Polari H; Meriö L; Mäkinen P; Weeks I
    Clin Chem; 2017 Apr; 63(4):908-914. PubMed ID: 28209627
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Creatine kinase-MM concentration in dried blood spots from newborns and implications for newborn screening for Duchenne muscular dystrophy.
    Park S; Maloney B; Caggana M; Tavakoli NP
    Muscle Nerve; 2022 Jun; 65(6):652-658. PubMed ID: 35307847
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Newborn screening and genomic analysis of duchenne muscular dystrophy in Henan, China.
    Jia C; Zhao D; Li Y; Gao Y; Zhang X; Li X; Lv S; Li R; Zhu X; Liu S
    Clin Chim Acta; 2023 Jan; 539():90-96. PubMed ID: 36516925
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evidence-based path to newborn screening for Duchenne muscular dystrophy.
    Mendell JR; Shilling C; Leslie ND; Flanigan KM; al-Dahhak R; Gastier-Foster J; Kneile K; Dunn DM; Duval B; Aoyagi A; Hamil C; Mahmoud M; Roush K; Bird L; Rankin C; Lilly H; Street N; Chandrasekar R; Weiss RB
    Ann Neurol; 2012 Mar; 71(3):304-13. PubMed ID: 22451200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Duchenne muscular dystrophy newborn screening: the first 50,000 newborns screened in Taiwan.
    Chien YH; Lee NC; Weng WC; Chen LC; Huang YH; Wu CS; Hwu WL
    Neurol Sci; 2022 Jul; 43(7):4563-4566. PubMed ID: 35562557
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of the GSP Creatine Kinase-MM Assay and Assessment of CK-MM Stability in Newborn, Patient, and Contrived Dried Blood Spots for Newborn Screening for Duchenne Muscular Dystrophy.
    Migliore BA; Zhou L; Duparc M; Robles VR; Rehder CW; Peay HL; Kucera KS
    Int J Neonatal Screen; 2022 Jan; 8(1):. PubMed ID: 35225934
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Duchenne Muscular Dystrophy Newborn Screening: Evaluation of a New GSP
    Timonen A; Lloyd-Puryear M; Hougaard DM; Meriö L; Mäkinen P; Laitala V; Pölönen T; Skogstrand K; Kennedy A; Airenne S; Polari H; Korpimäki T
    Int J Neonatal Screen; 2019 Sep; 5(3):27. PubMed ID: 33072986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum creatine kinase isoenzymes in Duchenne muscular dystrophy determined by sensitive enzyme immunoassay methods.
    Mokuno K; Riku S; Sugimura K; Takahashi A; Kato K; Osugi S
    Muscle Nerve; 1987 Jun; 10(5):459-63. PubMed ID: 3302699
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical and experimental results on cardiac troponin expression in Duchenne muscular dystrophy.
    Hammerer-Lercher A; Erlacher P; Bittner R; Korinthenberg R; Skladal D; Sorichter S; Sperl W; Puschendorf B; Mair J
    Clin Chem; 2001 Mar; 47(3):451-8. PubMed ID: 11238296
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Newborn bloodspot screening for Duchenne muscular dystrophy: 21 years experience in Wales (UK).
    Moat SJ; Bradley DM; Salmon R; Clarke A; Hartley L
    Eur J Hum Genet; 2013 Oct; 21(10):1049-53. PubMed ID: 23340516
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Comparison analysis of muscle enzymes in children with myocarditis and Duchene/Becker muscular dystrophy].
    Zhang Y; Wang H; Yu X; Xing Y; Wang C; He R
    Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2016 Sep; 41(9):984-91. PubMed ID: 27640799
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Screening for Duchenne muscular dystrophy in Germany, 1977-2011: A personal story.
    Scheuerbrandt G
    Muscle Nerve; 2018 Feb; 57(2):185-188. PubMed ID: 28981144
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identifying Non-Duchenne Muscular Dystrophy-Positive and False Negative Results in Prior Duchenne Muscular Dystrophy Newborn Screening Programs: A Review.
    Gatheridge MA; Kwon JM; Mendell JM; Scheuerbrandt G; Moat SJ; Eyskens F; Rockman-Greenberg C; Drousiotou A; Griggs RC
    JAMA Neurol; 2016 Jan; 73(1):111-6. PubMed ID: 26594870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Alterations in creatine kinase in fresh muscle and cell cultures in Duchenne dystrophy.
    Ionasescu V; Ionasescu R; Feld R; Witte D; Cancilla P; Kaeding L; Stern LZ
    Ann Neurol; 1981 Apr; 9(4):394-9. PubMed ID: 7224603
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Study on newborn screening for Duchenne muscular dystrophy and diagnostic strategy].
    Bao Y; Pan X; Pan J; Pan S; Zhuang D; Li H; Cao Z
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2021 May; 38(5):430-434. PubMed ID: 33974249
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Screening for Duchenne muscular dystrophy: an improved screening test for creatine kinase and its application in an infant screening program.
    Scheuerbrandt G; Lundin A; Lövgren T; Mortier W
    Muscle Nerve; 1986 Jan; 9(1):11-23. PubMed ID: 3951477
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum creatine kinase BB and MM concentrations determined by radioimmunoassay in neuromuscular disorders.
    Zweig MH; Adornato B; Van Steirteghem AC; Engel WK
    Ann Neurol; 1980 Apr; 7(4):324-8. PubMed ID: 7377757
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Implementation of Hospital-Based Supplemental Duchenne Muscular Dystrophy Newborn Screening (sDMDNBS): A Pathway to Broadening Adoption.
    Parad RB; Sheldon Y; Bhattacharjee A
    Int J Neonatal Screen; 2021 Nov; 7(4):. PubMed ID: 34842620
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Development and validation of a sensitive immunoassay for the skeletal muscle isoform of creatine kinase.
    Lo KR; Hurst SM; Atkinson KR; Vandenbogaerde T; Beaven CM; Ingram JR
    J Sci Med Sport; 2010 Jan; 13(1):117-9. PubMed ID: 18976957
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Use of capillary Western immunoassay (Wes) for quantification of dystrophin levels in skeletal muscle of healthy controls and individuals with Becker and Duchenne muscular dystrophy.
    Beekman C; Janson AA; Baghat A; van Deutekom JC; Datson NA
    PLoS One; 2018; 13(4):e0195850. PubMed ID: 29641567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.